JP2012530765A5 - - Google Patents

Download PDF

Info

Publication number
JP2012530765A5
JP2012530765A5 JP2012516757A JP2012516757A JP2012530765A5 JP 2012530765 A5 JP2012530765 A5 JP 2012530765A5 JP 2012516757 A JP2012516757 A JP 2012516757A JP 2012516757 A JP2012516757 A JP 2012516757A JP 2012530765 A5 JP2012530765 A5 JP 2012530765A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
unsubstituted
alkoxy
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012516757A
Other languages
English (en)
Japanese (ja)
Other versions
JP5685247B2 (ja
JP2012530765A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/059044 external-priority patent/WO2010149761A1/en
Publication of JP2012530765A publication Critical patent/JP2012530765A/ja
Publication of JP2012530765A5 publication Critical patent/JP2012530765A5/ja
Application granted granted Critical
Publication of JP5685247B2 publication Critical patent/JP5685247B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012516757A 2009-06-25 2010-06-25 結核を処置するための組成物 Active JP5685247B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09163765.2 2009-06-25
EP09163765 2009-06-25
PCT/EP2010/059044 WO2010149761A1 (en) 2009-06-25 2010-06-25 Composition for treatment of tuberculosis

Publications (3)

Publication Number Publication Date
JP2012530765A JP2012530765A (ja) 2012-12-06
JP2012530765A5 true JP2012530765A5 (enExample) 2013-08-08
JP5685247B2 JP5685247B2 (ja) 2015-03-18

Family

ID=41128169

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012516757A Active JP5685247B2 (ja) 2009-06-25 2010-06-25 結核を処置するための組成物

Country Status (5)

Country Link
US (1) US8912329B2 (enExample)
EP (1) EP2445495A1 (enExample)
JP (1) JP5685247B2 (enExample)
CN (1) CN102458393B (enExample)
WO (1) WO2010149761A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3000065A1 (fr) * 2012-12-21 2014-06-27 Univ Lille Ii Droit & Sante Composes bicycliques ayant une activite potentialisatrice de l'activite d'un antibiotique actif contre les mycobacteries-composition et produit pharmaceutiques comprenant de tels composes
FR3000064A1 (fr) 2012-12-21 2014-06-27 Univ Lille Ii Droit & Sante Composes de type spiroisoxazoline ayant une activite potentialisatrice de l'activite d'un antibiotique-composition et produit pharmaceutiques comprenant de tels composes
CA2914178C (en) 2013-01-07 2023-06-13 University Of Southern California Deoxyuridine triphosphatase inhibitors
MA40759A (fr) 2014-09-26 2017-08-01 Pfizer Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation
WO2017006271A1 (en) 2015-07-08 2017-01-12 University Of Southern California Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage
WO2017006270A1 (en) 2015-07-08 2017-01-12 University Of Southern California Deoxyuridine triphosphatase inhibitors
US10544105B2 (en) 2015-07-08 2020-01-28 Cv6 Therapeutics (Ni) Limited Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage
PT3319939T (pt) 2015-07-08 2025-03-05 Cv6 Therapeutics Ni Ltd Inibidores de desoxiuridina-trifosfatase contendo hidantoína
WO2018098204A1 (en) 2016-11-23 2018-05-31 Cv6 Therapeutics (Ni) Limited 6-membered uracil isosteres
US11168059B2 (en) 2016-11-23 2021-11-09 Cv6 Therapeutics (Ni) Limited Amino sulfonyl compounds
US11014924B2 (en) 2016-11-23 2021-05-25 Cv6 Therapeutics (Ni) Limited Hydantoin containing deoxyuridine triphosphatase inhibitors
US10829457B2 (en) 2016-11-23 2020-11-10 Cv6 Therapeutics (Ni) Limited Nitrogen ring linked deoxyuridine triphosphatase inhibitors
US10858344B2 (en) 2016-11-23 2020-12-08 Cv6 Therapeutics (Ni) Limited Hydantoin containing deoxyuridine triphosphatase inhibitors
WO2018128720A1 (en) 2017-01-05 2018-07-12 Cv6 Therapeutics (Ni) Limited Uracil containing compounds
CN108624641A (zh) * 2018-04-10 2018-10-09 佛山科学技术学院 一种通过合成生物学制备乙硫异烟胺烟酰胺腺嘌呤二核苷酸的方法
WO2025104491A1 (en) 2023-11-14 2025-05-22 Mindset Pharma Inc. Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto
WO2026013449A2 (en) * 2024-07-11 2026-01-15 Sea4Us - Biotecnologia E Recursos Marinhos, Sa Oxazolidone-derived compounds and their use in the treatment of chronic and acute pain

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB872448A (en) * 1958-12-23 1961-07-12 Lepetit Spa 1-acyl-3 substituted azetidines
GB872488A (en) 1959-01-19 1961-07-12 Nat Res Dev Improvements in or relating to voltage-measuring circuits
DE4127111A1 (de) 1990-08-24 1992-02-27 Basf Ag Verfahren zur herstellung von 3-pyrrolin-2-onen
US6372752B1 (en) 2000-02-07 2002-04-16 Genzyme Corporation Inha inhibitors and methods of use thereof
AU2005240784C1 (en) * 2004-05-07 2011-12-22 Janssen Pharmaceutica N.V. Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
FR2903405B1 (fr) 2006-07-04 2011-09-09 Pasteur Institut Composes a effet potentialisateur de l'activite de l'ethionamide et leurs applications
US9050295B2 (en) 2007-12-21 2015-06-09 Eth Zurich Composition for treatment of tuberculosis
DE102007062691A1 (de) 2007-12-21 2009-06-25 Beiersdorf Ag Wirkstoffkombinationen aus Anisfruchtextrakt und einem oder mehreren 2,3-Dibenzylbutyrolactonen
WO2009086303A2 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms

Similar Documents

Publication Publication Date Title
JP2012530765A5 (enExample)
JP2008520742A5 (enExample)
JP2021534124A5 (enExample)
CA2796967A1 (en) Heterocyclic derivatives as alk inhibitors
EA201290260A1 (ru) Бензимидазол-имидазольные производные
JP2010538076A5 (enExample)
JP2008526724A5 (enExample)
JP2009533410A5 (enExample)
JP2010525023A5 (enExample)
JP2008517926A5 (enExample)
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
JP2011518811A5 (enExample)
KR20090043506A (ko) 에티온아미드 활성 강화 효과를 갖는 화합물 및 그 용도
RU2005136368A (ru) Производные пиперазина и их применение для лечения неврологических и психиатрических заболеваний
JP2014530900A5 (enExample)
JP2011515462A5 (enExample)
JP2011519854A5 (enExample)
BR122017003188A2 (pt) composto 1-{2-[4-(2-amino-5-cloro-3-piridinil)fenóxi]-5-pirimidinil}-3-[2-(metilsulfonil)-5-(trifluorometil)fenil]ureia, sal deste, composição farmacêutica compreendendo-os e uso destes para o tratamento de câncer
NO20072371L (no) Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister
NZ627750A (en) Carbamate compounds and of making and using same
RU2008112691A (ru) Азотсодержащее гетероциклическое соединение и его фармацевтическое применение
CY1106857T1 (el) Βενζαμιδια 4-(αμινομεθυλ)-πιπεριδινης ως 5ht4-ανταγωνιστες
MXPA05010816A (es) Derivados de 4-(4- (heterociclilalcox}fenil)- 1-(heterociclil- carbonil) piperidina y compuestos relacionados como antagonistas de h3 de la histamina para el tratamiento de enfermedades neurologicas tales como alzheimer.
JP2012507535A5 (enExample)
RU2010145463A (ru) Производные замещенного 2-фенилпиридина